Phase 1, randomized, crossover study comparing intravenous GTX-104 to oral nimodipine in healthy human subjects.

Kumar A, D'Andrea C, Kohli P, Kottayil SG, Longstreth J, Macdonald RL

Open source

DOI
10.1371/journal.pone.0323162
Published
2025
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0323162,
  title = {Phase 1, randomized, crossover study comparing intravenous GTX-104 to oral nimodipine in healthy human subjects.},
  author = {Kumar A and D'Andrea C and Kohli P and Kottayil SG and Longstreth J and Macdonald RL},
  year = {2025},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0323162},
  url = {https://doi.org/10.1371/journal.pone.0323162}
}

RIS

TY  - JOUR
TI  - Phase 1, randomized, crossover study comparing intravenous GTX-104 to oral nimodipine in healthy human subjects.
AU  - Kumar A
AU  - D'Andrea C
AU  - Kohli P
AU  - Kottayil SG
AU  - Longstreth J
AU  - Macdonald RL
PY  - 2025
JO  - PloS one
DO  - 10.1371/journal.pone.0323162
UR  - https://doi.org/10.1371/journal.pone.0323162
ER  - 

APA

A, K., C, D., P, K., SG, K., J, L., & RL, M. (2025). Phase 1, randomized, crossover study comparing intravenous GTX-104 to oral nimodipine in healthy human subjects.. PloS one. https://doi.org/10.1371/journal.pone.0323162

Source records